Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1995
12/12/1995US5475013 Inhibit human immunodeficiency virus protease
12/12/1995US5475011 Administering novel taxanes for treating ovarian, breast, non-small cell lung and colon cancers
12/12/1995US5475010 Vaginal infections
12/12/1995US5475008 Quinolone derivatives
12/12/1995US5475007 Preventing convulsions
12/12/1995US5475006 Mixed oxidation products which cannot form Vitamin A
12/12/1995US5475005 Benzimidazole anthelmintic agents
12/12/1995US5475004 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
12/12/1995US5475002 Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
12/12/1995US5475001 Receptor tyrosine kinase inhibitory; anticarcinogenic agent
12/12/1995US5475000 3-(substituted tetrazolyl)-4-oxo-4H-pyrido-[1,2-a]pyrimidines, salts thereof, pharmaceutical compositions containing them and process for preparing same
12/12/1995US5474999 Therapeutic amides
12/12/1995US5474997 Methods and compositions of (2R,4S) itraconazole for treating fungal yeast and dermatophyte infections
12/12/1995US5474996 Angiotension II inhibitors
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474993 7-oxo-6-amino-4-thia-1-azabicycl(3.2.0) heptanes; anticholesterol agents
12/12/1995US5474992 Administering a phosphoric acid diester for the prophylaxis and kidney urogenital disorders, as free radical antagonist
12/12/1995US5474991 Lipid metabolism improving medicinal composition
12/12/1995US5474990 Preventing brain damage from hypoxia/ischemia caused by stroke, cardiac arrest
12/12/1995US5474989 Drug composition
12/12/1995US5474988 Analgesics, antiinflammatory agents
12/12/1995US5474987 Methods of using low molecular weight heparins treatment of pathological processes
12/12/1995US5474986 Method for treating galabiose-binding bacteria infections
12/12/1995US5474985 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474782 Wound-healing composition and method
12/12/1995US5474779 Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect
12/12/1995US5474775 A water in oil emulsion having a fatty phase; excellent spreading, high viscosity, organoleptic
12/12/1995US5474774 Adhesion inhibiting composition
12/12/1995US5474768 Vaginal tissue moisturizing composition and method
12/12/1995US5474767 Polyamines and method for preparation thereof
12/12/1995US5474763 Reduction of hair growth
12/12/1995US5474761 Mixture of bactericide and bicarbonate salt
12/12/1995US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
12/12/1995US5474759 Non-chlorofluorocarbon aerosol formulations
12/12/1995US5474757 Administering diallyl sulfone to prevent metabolism of acetaminophen into hepatotoxic metabolites
12/12/1995US5474547 Parkinson disease, epilepsy
12/12/1995CA2070388C Antihypertensive compositions and use thereof
12/12/1995CA2051813C Preparation for care of nails, skin and hair
12/12/1995CA2010692C Gelatin capsules containing ranitidine
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/11/1995CA2151113A1 Imidazolinyl tachykinin receptor antagonists
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/09/1995CA2150960A1 Use of n-[[5-(naphthalen-1-yl)-1,3-dioxan-2-yl]alkyl] -acetamide derivatives for the preparation of medicinal products which are useful in the treatment of neurodegenerative disorders
12/08/1995CA2148977A1 Methods for the inhibition of platelet adherence and aggregation
12/07/1995WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995WO1995032987A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/07/1995WO1995032986A1 Branched oligonucleotides as pathogen-inhibitory agents
12/07/1995WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995WO1995032984A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs
12/07/1995WO1995032983A1 Post exposure prevention of hiv
12/07/1995WO1995032980A1 Synthesis of oligonucleotides
12/07/1995WO1995032976A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
12/07/1995WO1995032975A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
12/07/1995WO1995032974A1 Carbazole derivatives as agents against multi-drug resistance
12/07/1995WO1995032973A1 The preparation of nalbuphine having low levels of beta-epimer
12/07/1995WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
12/07/1995WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032967A1 Amide derivatives having 5ht1d-antagonist activity
12/07/1995WO1995032966A1 Indole derivatives as prodrugs of 5-ht1-like receptor agonists
12/07/1995WO1995032962A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995WO1995032961A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995WO1995032949A1 Gastrin and cck antagonists
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions
12/07/1995WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
12/07/1995WO1995032737A1 Pharmaceutical composition
12/07/1995WO1995032723A1 Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation
12/07/1995WO1995032719A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
12/07/1995WO1995032718A1 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
12/07/1995WO1995032717A1 The use of an anti-helicobacter substance
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995WO1995032714A1 Arteriosclerosis depressant
12/07/1995WO1995032713A1 Solid dispersion of thiazolidine derivative or pharmaceutical preparation comprising said dispersion
12/07/1995WO1995032712A1 Compounds and compositions for administration via oral inhalation or insufflation
12/07/1995WO1995032711A1 Use of intravenously administered iron in the therapy of tumoral and infectious diseases
12/07/1995WO1995032710A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/07/1995WO1995032709A1 Activation of growth factors by matrix vesicles
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents
12/07/1995WO1995029165A3 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
12/07/1995WO1995024485A3 Coordinate in vivo gene expression
12/07/1995WO1993015713A3 Method and compositions for treating acne
12/07/1995DE4419315A1 New hetero- and oxo-pyrrolizine derivs.
12/07/1995DE4419256A1 Intravenous admin of iron
12/07/1995DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
12/07/1995DE4419246A1 New hetero-aryl substd. pyrrolizine derivs.
12/07/1995CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof
12/07/1995CA2191710A1 Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation
12/07/1995CA2191576A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995CA2191575A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995CA2191192A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2190998A1 Branched oligonucleotides as pathogen-inhibitory agents
12/07/1995CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995CA2190870A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/07/1995CA2190862A1 Post exposure prevention of hiv
12/07/1995CA2190750A1 Arteriosclerosis depressant
1 ... 6961 6962 6963 6964 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 ... 7860